Skip to content

Clinical trials

Phase 3 Venous Thromboembolism trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Phase 3 Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20073
20085
20091
20101
20131
20142
20151
20172
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Daiichi Sankyo3
Anthos Therapeutics, Inc.2
Boehringer Ingelheim2
Sanofi2
Fadoi Foundation, Italy1
GlaxoSmithKline1
Johns Hopkins All Children's Hospital1
Martini Hospital Groningen1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism21
Venous Thrombosis12
Pulmonary Embolism8
Neoplasms3
Thromboembolism3
Thrombosis2
Gastrointestinal Neoplasms1
Postpartum Hemorrhage1
Postthrombotic Syndrome1
Pre-Eclampsia1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.